Xeris Biopharma Holdings (XERS) Capital Expenditures Growth (1y) (2021)

Xeris Biopharma Holdings (XERS) Capital Expenditures Growth (1y) (2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Haleon 89.91 Bn 88.04 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.17 Bn 1.97 Bn 32.28%
3 Zoetis 32.54 Bn 30.60 Bn 1.62 Bn -38.20%
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -15.72%
5 United Therapeutics 23.05 Bn 20.89 Bn 648.10 Mn 32.98%
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -6.34%
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn -86.92%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -21.54%
10 Xeris Biopharma Holdings 1.42 Bn 1.31 Bn 72.55 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 -41.78%